Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175085 | SCV000226513 | uncertain significance | not provided | 2015-05-05 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000175085 | SCV001475334 | uncertain significance | not provided | 2021-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000175085 | SCV002258325 | likely pathogenic | not provided | 2022-10-21 | criteria provided, single submitter | clinical testing | This variant, c.1560_1562del, results in the deletion of 1 amino acid(s) of the OPA1 protein (p.Glu521del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 194662). This variant has been observed in individuals with clinical features of dominant optic atrophy (PMID: 19319978, 31673222, 34242285; Invitae). It has also been observed to segregate with disease in related individuals. |
Gene |
RCV000175085 | SCV005201499 | likely pathogenic | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22042570, 31673222, 19319978, 34242285) |
Institute of Human Genetics, |
RCV004816266 | SCV005069425 | uncertain significance | Optic atrophy | 2023-01-01 | no assertion criteria provided | clinical testing |